These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 21777198)
1. Targeting aurora kinases in cancer treatment. Kelly KR; Ecsedy J; Mahalingam D; Nawrocki ST; Padmanabhan S; Giles FJ; Carew JS Curr Drug Targets; 2011 Dec; 12(14):2067-78. PubMed ID: 21777198 [TBL] [Abstract][Full Text] [Related]
2. Aurora-B kinase inhibitors for cancer chemotherapy. Yeung SC; Gully C; Lee MH Mini Rev Med Chem; 2008 Dec; 8(14):1514-25. PubMed ID: 19075809 [TBL] [Abstract][Full Text] [Related]
3. Aurora B: a new prognostic marker and therapeutic target in cancer. Portella G; Passaro C; Chieffi P Curr Med Chem; 2011; 18(4):482-96. PubMed ID: 21143115 [TBL] [Abstract][Full Text] [Related]
4. Growth suppression and mitotic defect induced by JNJ-7706621, an inhibitor of cyclin-dependent kinases and aurora kinases. Matsuhashi A; Ohno T; Kimura M; Hara A; Saio M; Nagano A; Kawai G; Saitou M; Takigami I; Yamada K; Okano Y; Shimizu K Curr Cancer Drug Targets; 2012 Jul; 12(6):625-39. PubMed ID: 22463590 [TBL] [Abstract][Full Text] [Related]
5. Aurora kinases: new targets for cancer therapy. Carvajal RD; Tse A; Schwartz GK Clin Cancer Res; 2006 Dec; 12(23):6869-75. PubMed ID: 17145803 [TBL] [Abstract][Full Text] [Related]
6. Aurora A and B kinases--targets of novel anticancer drugs. Libertini S; Abagnale A; Passaro C; Botta G; Portella G Recent Pat Anticancer Drug Discov; 2010 Nov; 5(3):219-41. PubMed ID: 20524930 [TBL] [Abstract][Full Text] [Related]
7. Clinical experience with aurora kinase inhibitors: a review. Boss DS; Beijnen JH; Schellens JH Oncologist; 2009 Aug; 14(8):780-93. PubMed ID: 19684075 [TBL] [Abstract][Full Text] [Related]
8. Aurora kinase inhibitors: a new class of drugs targeting the regulatory mitotic system. Pérez Fidalgo JA; Roda D; Roselló S; Rodríguez-Braun E; Cervantes A Clin Transl Oncol; 2009 Dec; 11(12):787-98. PubMed ID: 20045785 [TBL] [Abstract][Full Text] [Related]
9. Aurora kinase inhibitors as anticancer molecules. Katayama H; Sen S Biochim Biophys Acta; 2010; 1799(10-12):829-39. PubMed ID: 20863917 [TBL] [Abstract][Full Text] [Related]
10. The Aurora kinase family in cell division and cancer. Vader G; Lens SM Biochim Biophys Acta; 2008 Sep; 1786(1):60-72. PubMed ID: 18662747 [TBL] [Abstract][Full Text] [Related]
17. PF-03814735, an orally bioavailable small molecule aurora kinase inhibitor for cancer therapy. Jani JP; Arcari J; Bernardo V; Bhattacharya SK; Briere D; Cohen BD; Coleman K; Christensen JG; Emerson EO; Jakowski A; Hook K; Los G; Moyer JD; Pruimboom-Brees I; Pustilnik L; Rossi AM; Steyn SJ; Su C; Tsaparikos K; Wishka D; Yoon K; Jakubczak JL Mol Cancer Ther; 2010 Apr; 9(4):883-94. PubMed ID: 20354118 [TBL] [Abstract][Full Text] [Related]
18. Aurora kinase inhibitors: progress towards the clinic. Kollareddy M; Zheleva D; Dzubak P; Brahmkshatriya PS; Lepsik M; Hajduch M Invest New Drugs; 2012 Dec; 30(6):2411-32. PubMed ID: 22350019 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of Aurora kinase inhibitors in cancer. Naruganahalli KS; Lakshmanan M; Dastidar SG; Ray A Curr Opin Investig Drugs; 2006 Dec; 7(12):1044-51. PubMed ID: 17209521 [TBL] [Abstract][Full Text] [Related]
20. Aurora kinases: structure, functions and their association with cancer. Kollareddy M; Dzubak P; Zheleva D; Hajduch M Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2008 Jun; 152(1):27-33. PubMed ID: 18795071 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]